KISSEI PHARMACEUTICAL – Fell for the first time in 3 days; review results for Tavneos reported by the Second Committee on Pharmaceuticals, with a move to halt new prescriptions

The story

Kissei Pharmaceutical drew market attention and fell for the first time in 3 days. The results of deliberations concerning TabNeos were reported at the Second Subcommittee on Pharmaceutical Products.

The deliberations indicated a policy of discontinuing new administrations, and attention is focused on the company’s response going forward.

At a glance

Event typeThe results of deliberations concerning TabNeos were reported.

Nature of the resultA policy to discontinue new administrations has been reported.

Relevant departmentDeliberations and a report were held at the Second Subcommittee on Pharmaceutical Products.

Reference information. Every claim resolves to something the story actually named.

Where this came from

We read each source in full and checked they agree on the core claim.

1/ 1 agree

All of them report the same thing.

www.tradingview.comNews

AgreesOpen

Read the original articleGo to the source page

Reference information generated from public sources. It does not solicit or advise on investments. Prices are 15-minute delayed.